The South Korean pharma company’s US subsidiary is purchasing Eli Lilly’s Branchburg, NJ site to safeguard against potential ...

Ullrich Mayeski, community engagement director of health with GS1 US, explains how with over a decade of collaboration, ...

This episode of Pharma Pulse covers ACIP’s move toward shared decision-making for COVID-19 vaccines, Pfizer’s acquisition of ...

The platform enables clinicians to tailor GLP-1 titration at scale, aiming to reduce discontinuation rates and improve ...

Ullrich Mayeski, community engagement director of health with GS1 US, describes of the organization’s EPCIS standard for meeting DSCSA requirements while underscoring that true supply chain success ...

This episode of Pharma Pulse covers the CDC’s decision to postpone changes to Hepatitis B vaccine guidance, new research ...

New bipartisan legislation would give the FDA authority to modernize prescribing information, reducing waste while improving ...

Takeda will be shipping treatments between Europe and the US using VELA’s sailing cargo trimaran, potentially reducing ...

Industry leaders—from manufacturers, distributors, and dispensers—reported increased preparedness for compliance, with discussions shifting toward exception management, governance, and enforcement ...

The new Goochland County facility will serve as Lilly’s first fully integrated API and drug product site, focusing on ...

This episode of Pharma Pulse covers GSK’s $30 billion plan to expand US biopharma production, new evidence that weekly GLP-1 therapies significantly reduce cardiovascular risks, and Roche’s ...

The pharmaceutical giant’s commitment includes a $1.2 billion investment in advanced facilities powered by AI and digital ...